PHARMACY

Sen. Mark Pryor, columnist Mort Kondracke to address NACDS RxImpact Day attendees

BY Antoinette Alexander

ALEXANDRIA, Va. — The National Association of Chain Drug Stores has announced that it will hold its fourth annual NACDS RxImpact Day on Capitol Hill on March 21 to 22 in Washington, D.C.

The event will bring pharmacists, pharmacy leaders, students and other pharmacy advocates to meet with lawmakers to discuss the value of community pharmacy in improving health and reducing healthcare costs across the board.

“Just as community pharmacy highlights the value of the patient-pharmacist relationship, there is a high value placed on the interaction of pharmacy advocates engaging with lawmakers,” NACDS president and CEO Steve Anderson said. “The NACDS RxImpact Day on Capitol Hill is an important opportunity for community pharmacy advocates to engage with lawmakers on pro-patient, pro-pharmacy issues.”

During the two-day event, pharmacy advocates will conduct hundreds of individual meetings with lawmakers and their staffs on behalf of community pharmacy.  Advocates will discuss a variety of issues including medication therapy management, protecting fair and accurate reimbursement in the Medicaid program and issues related to pharmacy benefit managers.

This year’s event also will include insights on the health care and pharmacy landscape in this Presidential election year.  Roll Call political columnist and television personality from “The McLaughlin Group” and Fox News Channel Mort Kondracke will address attendees during the Welcome Dinner on March 21.

Sen. Mark Pryor, D-Ark., will serve as the keynote speaker at the Breakfast Briefing on March 22.  Sen. Pryor is the sponsor of the bipartisan legislation S. 1058, the Pharmacy Competition and Consumer Choice Act of 2011, which would preserve pharmacy choice for patients and take additional steps to prevent threats to pharmacy patient care.

“Community pharmacies are located in every congressional district across the country, providing important patient services that help improve health and reduce costs including medication counseling, vaccinations and health screenings. We urge pharmacy advocates to engage on key issues that impact community pharmacy and patient care by participating in the NACDS RxImpact Day on Capitol Hill,” Anderson added.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Medco launches specialty benefit management program

BY Alaric DeArment

FRANKLIN LAKES, N.J. — Pharmacy benefit manager Medco Health Solutions has launched a medical benefit management program that it said would help control spending on specialty drugs, the company said.

Medco said the program, implemented under a partnership with software developer NovoLogix, would help to better manage specialty drugs covered under major medical plans by bringing greater efficiencies around the coverage of them, while reducing some of the estimated $8 billion in waste incurred each year. The company said medical benefit management would allow it to provide increased cost transparency to health plans and employers that cover specialty drugs under their medical plans. Specialty drugs are medications used to treat complex and chronic health conditions, such as cancers, autoimmune disorders and chronic viral infections.

"We developed this program in order to extend the best practices in specialty pharmacy to major medical coverage," said Frank Sheehy, president of Medco subsidiary Accredo Health Group. "Historically, health insurers and other payers have not focused on the prevention of waste or the management of specialty drugs that fall within the medical benefit."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Former pharmaceutical executive takes on new role at Fuse Science

BY Allison Cerra

MIAMI LAKES, Fla. — Fuse Science announced that one of its advisory board members has taken on a new role.

Jeanne Hebert, a 20-year industry veteran, will become VP marketing and clinical research, effectively immediately. Her responsibilities will include advancing product innovation through development and commercialization phases, including work with suppliers on product design and advanced medical prototyping.

Prior to her new role, Hebert worked for such companies as Bristol-Myers Squibb, Bayer Pharmaceuticals, Merck and Integral Orthopedics.

In addition to Hebert’s appointment, Fuse Science also announced that Julie Zastrow to the management team to lead its grass roots marketing, athlete management and social media efforts. She formerly was VP marketing and merchandising for apparel brand Tapout.

"We are very pleased to have Jeanne & Julie join our team," Fuse Science president and COO Rubin Hanan said. "We are aggressively driving our product commercialization efforts, continued research and athlete strategy for the Powered By Fuse brand. The full-time commitment of Ms. Herbert and Ms. Zastrow to our business brings immediate positive impact and advancement to this strategy."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?